Marché Fermé -
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
0,3696 USD | +8,77 % | +14,78 % | -52,85 % |
Métier
Nombre d'employés: 6
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
David Mehalick
CEO | Chief Executive Officer | 56 | 28/10/22 |
Brian Cogley
DFI | Director of Finance/CFO | 38 | 17/05/23 |
Daniel Yerace
COO | Chief Operating Officer | 41 | 28/10/22 |
Colleen Delaney
CTO | Chief Tech/Sci/R&D Officer | 57 | 30/08/23 |
Christine Sheehy
CMP | Compliance Officer | 57 | 28/10/22 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Director/Board Member | 62 | 28/10/22 | |
Director/Board Member | 55 | 28/10/22 | |
Christine Sheehy
CMP | Compliance Officer | 57 | 28/10/22 |
Gene Salkind
BRD | Director/Board Member | 71 | 28/10/22 |
Chris Calise
BRD | Director/Board Member | 51 | 28/10/22 |
David Mehalick
CEO | Chief Executive Officer | 56 | 28/10/22 |
Daniel Yerace
COO | Chief Operating Officer | 41 | 28/10/22 |
Director/Board Member | 56 | 28/10/22 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 36 089 917 | 24 345 215 ( 67,46 %) | 0 | 67,46 % |
Coordonnées société
Coeptis Therapeutics Holdings, Inc.
105 Bradford Road Suite 420
15090, Wexford
+
http://www.coeptistx.comSecteur
Révisions de BNA
Varia. 1 janv. | Capi. | |
---|---|---|
-52,85 % | 13,34 M | |
+29,68 % | 681 Md | |
+21,57 % | 556 Md | |
-4,35 % | 361 Md | |
+17,65 % | 325 Md | |
+3,77 % | 285 Md | |
+13,75 % | 235 Md | |
+4,57 % | 199 Md | |
-12,31 % | 189 Md | |
-3,79 % | 157 Md |
- Bourse
- Actions
- Action COEP
- Société Coeptis Therapeutics Holdings, Inc.